低资源环境下轮状病毒疫苗效果:检测阴性设计的评价
本研究基于非洲撒哈拉以南和亚洲的三项大型随机安慰剂对照试验数据库,采用检测阴性设计(TND)估算单价(RV1)和五价(RV5)轮状病毒疫苗效果,并与原随机对照试验的疫苗效力估计值比较。结果显示TND疫苗效果估计值与原随机对照试验效力估计值几乎相等,且两种疫苗对轮状病毒阴性腹泻均无实质性影响。研究支持TND可作为在低资源环境下测量轮状病毒疫苗效果的适宜流行病学研究设计。
要点
- TND疫苗效果估计值与原随机对照试验疫苗效力估计值几乎相等。
- RV1和RV5对轮状病毒阴性腹泻均无实质性影响,符合TND核心假设。
- 研究支持TND作为低资源环境下测量轮状病毒疫苗效果的适宜设计。
核心结论
- 本研究支持检测阴性设计(TND)可作为在低资源环境下测量轮状病毒疫苗效果的适宜流行病学研究设计。
研究设计与样本
- 本研究基于三项在撒哈拉以南非洲和亚洲开展的大型随机安慰剂对照试验数据库,采用检测阴性设计估算单价(RV1)和五价(RV5)轮状病毒疫苗效果。
主要发现
- TND疫苗效果估计值与原随机对照试验疫苗效力估计值几乎相等。
- RV1和RV5对轮状病毒阴性腹泻均无实质性影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The test-negative design (TND), an epidemiologic method currently used to measure rotavirus vaccine (RV) effectiveness, compares the vaccination status of rotavirus-positive cases and rotavirus-negative controls meeting a pre-defined case definition for acute gastroenteritis. Despite the use of this study design in low-income settings, the TND has not been evaluated to measure rotavirus vaccine effectiveness. METHODS: This study builds upon prior methods to evaluate the use of the TND for influenza vaccine using a randomized controlled clinical trial database. Test-negative vaccine effectiveness (VE-TND) estimates were derived from three large randomized placebo-controlled trials (RCTs) of monovalent (RV1) and pentavalent (RV5) rotavirus vaccines in sub-Saharan Africa and Asia. Derived VE-TND estimates were compared to the original RCT vaccine efficacy estimates (VE-RCTs). The core assumption of the TND (i.e., rotavirus vaccine has no effect on rotavirus-negative diarrhea) was also assessed. RESULTS: TND vaccine effectiveness estimates were nearly equivalent to original RCT vaccine efficacy estimates. Neither RV had a substantial effect on rotavirus-negative diarrhea. CONCLUSIONS: This study supports the TND as an appropriate epidemiologic study design to measure rotavirus vaccine effectiveness in low-income settings.
引用
- Schwartz LM, Halloran ME, Rowhani-Rahbar A, et al. Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design. Vaccine. 2016. PMID: 27876198. doi:10.1016/j.vaccine.2016.10.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。